DermaSensor
Health technology company designing tools to better equip primary care providers for skin cancer checks.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $10.0m Valuation: $57.5m | Early VC | |
| Total Funding | 000k | ||
Related Content
DermaSensor is a health technology company that has developed a handheld device for the early detection of skin cancer. The device is designed to be used by primary care physicians, enabling them to conduct non-invasive assessments of skin lesions during routine check-ups.
The core technology combines optical spectroscopy and artificial intelligence. By analyzing the light reflected from a skin lesion, the device's proprietary algorithms can assess the risk of cancer in real-time. This provides immediate results to the physician, helping them to make more informed decisions about whether to refer a patient to a specialist for further investigation.
The company's business model is focused on selling these devices to healthcare providers, including individual physician offices, health systems, and walk-in clinics. By equipping primary care physicians with this tool, DermaSensor aims to improve the early detection rates of skin cancer, which can lead to better patient outcomes and lower healthcare costs.
Keywords: skin cancer, medical device, primary care, artificial intelligence, spectroscopy, non-invasive, early detection, health technology, diagnostics, dermatology